March 16, 2021
38,459
134
0.35%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:25Now PlayingThere are three COVID-19 vaccines authorized for emergency use by the Food and Drug Administration, and experts say any kind of protection is better than none. Some people have expressed concern that the single-dose vaccine from Johnson & Johnson is 72-percent effective at preventing COVID-19 infection in the U.S, according to clinical data, a lower efficacy rate than the two-dose Pfizer or Moderna vaccines. Dr. Kimberly Manning of Grady Memorial Hospital in Atlanta told PBS NewsHour Senior Correspondent Amna Nawaz that the Johnson & Johnson vaccine is still very good at preventing infection, and that which vaccine you get is less important than getting one, period; any will help "protect yourself and your loved ones," Grady said. Whether Pfizer, Moderna, Johnson & Johnson or any vaccine that the FDA has authorized, "get the one that is in front of you," Manning added.
Stream your PBS favorites with the PBS app
Find more from PBS NewsHour at
Subscribe to our YouTube channel
Subscribe:
PBS NewsHour podcasts
Newsletters
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.